QQ客服 官方微博 反馈留言

	Metabonomics screening of serum identifies pyroglutamate as a diagnostic biomarker for nonalcoholic steatohepatitis
	Qi, Suwen[1]; Xu, Depeng[1]; Li, Qiaoliang[1]; Xie, Ni[2]; Xia, Jun[2]; Huo, Qin[2]; Li, Pu[3]; Chen, Qiwen[1]; Huang, Si[1]
刊名	CLINICA CHIMICA ACTA
	2017
卷号	473页码:89-95
关键词	Non-alcoholic fatty liver disease Nonalcoholic steatohepatitis Simple steatosis Metabolic profiling Pyroglutamate
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2184540
专题	华南理工大学
作者单位	1.[1]Shenzhen Univ, Sch Med, Dept Biomed Engn, Shenzhen 518060, Peoples R China 2.[2]Shenzhen Univ, Affiliated Hosp 1, Shenzhen Hosp 2, Shenzhen 518060, Peoples R China 3.[3]Chongqing Med Univ, Hosp 2, Dept Lab Med, Chongqing 410006, Peoples R China
推荐引用方式 GB/T 7714	Qi, Suwen[1],Xu, Depeng[1],Li, Qiaoliang[1],et al. Metabonomics screening of serum identifies pyroglutamate as a diagnostic biomarker for nonalcoholic steatohepatitis[J]. CLINICA CHIMICA ACTA,2017,473:89-95.
APA	Qi, Suwen[1].,Xu, Depeng[1].,Li, Qiaoliang[1].,Xie, Ni[2].,Xia, Jun[2].,...&Huang, Si[1].(2017).Metabonomics screening of serum identifies pyroglutamate as a diagnostic biomarker for nonalcoholic steatohepatitis.CLINICA CHIMICA ACTA,473,89-95.
MLA	Qi, Suwen[1],et al."Metabonomics screening of serum identifies pyroglutamate as a diagnostic biomarker for nonalcoholic steatohepatitis".CLINICA CHIMICA ACTA 473(2017):89-95.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。